Regulations
Neutral
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4
Breaking news from global financial markets
2 months ago
Read More
2 months ago
3,468
3 Cash-Heavy Stocks That Fall Short
Technology
2 months ago
1,656
2 months ago
756
2 months ago
1,642
2 months ago
3,087
2 months ago
4,935
2 months ago
1,367
2 months ago
879
2 months ago
1,555
Thursday's Economic Calendar
Markets
2 months ago
4,437
2 months ago
2,592
2 months ago
2,113
2 months ago
3,686
2 months ago
2,815
2 months ago
2,011
2 months ago
3,633
2 months ago
1,916
Planet 13 Revenue Drops 14% in Q2
Earnings
2 months ago
2,461
2 months ago
4,122
Trending Now
1
EUR/USD: There are still many clouds ahead of our EUR/USD forecast – Commerzbank
17,888
1 minute ago
2
Dimensional Fund Advisors Ltd. : Form 8.3 - TT ELECTRONICS PLC - Ordinary Shares
42,384
8 minutes ago
3
4
Multi-Tenant Data Centers Business Analysis Report 2025: Market to Reach $91 Bil...
17,999
11 minutes ago
5
Dimensional Fund Advisors Ltd. : Form 8.3 - DOWLAIS GROUP PLC - Ordinary Shares
11,266
11 minutes ago